Mazyar Shadman, MD, MPH

faculty member

Mazyar Shadman, MD, MPH

Associate Professor
Clinical Research Division, Fred Hutch

Innovators Network Endowed Chair
Fred Hutch

Fax: 206.667.1874
Mail Stop: D5-390

Dr. Mazyar Shadman is a blood cancer specialist who focuses on lymphoid malignancies. He is involved in clinical research using novel therapeutic agents for lymphoma and chronic lymphocytic leukemia, or CLL, as well as immunotherapy (specifically CAR T cell therapy) for lymphoid neoplasms and blood stem cell transplant for hematologic malignancies. His goal is to identify the best treatment sequence or combination for patients with high-risk lymphoma and CLL.

Other Appointments & Affiliations

Attending Physician, Hematologic Malignancies
Fred Hutchinson Cancer Center

Associate Professor, Medical Oncology Division
University of Washington School of Medicine


Hematology and Medical Oncology fellowship, University of Washington/Fred Hutchinson Cancer Center, 2011-2014

Internal Medicine Residency, Cleveland Clinic, 2008-2011

MPH, Cancer Epidemiology, University of Washington, 2008

MD, Tehran University of Medical Sciences, 2004

Research Interests

Therapeutic clinical trials in lymphoid malignancies with a focus on chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)

Clinical outcome research in hematopoietic cell transplantation

Epidemiology of hematologic malignancies

"My goal is to really bring what happens in the lab to the patient level, taking the research that is created by scientists at Fred Hutch and translating that to the patient."

— Dr. Mazyar Shadman

Find an Active Clinical Trial Led by Dr. Shadman

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210